The "Corneal Edema - Epidemiology Forecast - 2034" report has been added to ResearchAndMarkets.com's offering.A comprehensive report has been released providing valuable insights into the diagnosis, ...

Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") today announced it received regulatory approval to ...

Novo Nordisk announced plans for a longer phase III trial testing its investigational obesity drug CagriSema, with regulatory ...

ANI Pharmaceuticals offers an asymmetric opportunity in small-cap pharma, with a niche in generics, rare disease treatments, ...

Bayer seeks European approval of extended 6-month treatment interval for Eylea 8 mg to treat nAMD & diabetic macular edema: Berlin Tuesday, February 11, 2025, 10:00 Hrs [IST] Baye ...

I am grateful to Connecticut for banning the death penalty, but it is deeply troubling to me that Connecticut companies are ...

The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.

One of the oldest tricks in the book, a cold-spoon massage can work wonders on puffy eyes. “A cold-spoon massage is one of ...

Is your heart working fine or its in trouble? Here are the top 10 signs that clearly says your heart is struggling to ...

Regeneron Pharmaceuticals has announced results from the phase 3 QUASAR trial and its extension study of the phase 3 PULSAR ...

Company completed Type C meeting with FDA, aligning on its plan to submit an sNDA; submission expected around end of 1Q25If approved, FILSPARI ...